<sup>211</sup>At on gold nanoparticles for targeted radionuclide therapy application-Reference-Cited by-同舟云学术

²¹¹At on gold nanoparticles for targeted radionuclide therapy application

Published:2024 Issue:17 Volume:26 Page:12915-12927
ISSN:1463-9076
Container-title:Physical Chemistry Chemical Physics
language:en
Short-container-title:Phys. Chem. Chem. Phys.

Author:

Tanudji Jeffrey¹^ORCID,Kasai Hideaki²^ORCID,Okada Michio²³^ORCID,Ogawa Tetsuo²⁴,Aspera Susan M.⁵^ORCID,Nakanishi Hiroshi⁶^ORCID

Affiliation:

1. Department of Applied Physics, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan

2. Institute of Radiation Sciences, The University of Osaka, 1-1 Machikaneyama-cho, Toyonaka, Osaka 560-0043, Japan

3. Department of Chemistry, The University of Osaka, 1-1 Machikaneyama-cho, Toyonaka, Osaka 560-0043, Japan

4. Department of Physics, The University of Osaka, 1-1 Machikaneyama-cho, Toyonaka, Osaka 560-0043, Japan

5. Research Initiative for Supra-Materials, Shinshu University, 4-17-1 Wakasato, Nagano, Nagano 380-8553, Japan

6. National Institute of Technology, Akashi College, 679-3 Nishioka, Uozumi-cho, Akashi, Hyogo 674-8501, Japan

Abstract

Targeted Alpha Therapy (TAT) using 211At–AuNP is a new and growing field of multidisciplinary research that would ultimately provide the medical community with another way to treat cancer.

Funder

Osaka University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/CP/D3CP05326A

Reference141 articles.

1. National Institute of Health , Radiation Therapy to Treat Cancer , https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy (accessed August 2023)

2. W.Link , Principles of Cancer Treatment and Anticancer Drug Development , Springer International Publishing , Switzerland , 2019

3. Bringing the heavy: carbon ion therapy in the radiobiological and clinical context

4. Visualized Analysis of Heavy Ion Radiotherapy: Development, Barriers and Future Directions

5. Radioactive iodine, I-131, in the treatment of hyperthyroidism